Lipodystrophies Completed Phase 4 Trials for Riboflavin (DB00140)

Also known as: Lipodystrophy / Lipodystrophy NOS / Lipodystrophy acquired

IndicationStatusPhase
DBCOND0026618 (Lipodystrophies)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00202228Lactate Metabolism Study in HIV Infected PersonsHealth Services Research